Find clinical trials for Breast Cancer in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer

Cancer

Carcinoma

Endometrial Cancer

Non-Small-Cell Lung Carcinoma

Neoplasm Metastasis

Ovarian Cancer

Breast Cancer trials near Durham, NC, USA:

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain MetAstaSEs

The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast...

Enrolling

Breast Cancer

Breast Cancer Female

Drug: Datopotamab Deruxtecan

Phase 2

•

Sarah Sammons, MD

Durham, North Carolina, United States and 2 other locations

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...

Active, not recruiting

Inflammatory Breast Cancer (IBC)

Drug: Paclitaxel

Drug: Cyclophosphamide

Phase 2

•

Dana-Farber Cancer Institute

Durham, North Carolina, United States and 3 other locations

Promoting Resilience in Women With Breast Cancer (PRISM -MBC) (PRISMMBC)

outcomes for individuals with a recent diagnosis of metastatic breast cancer (MBC) participating in the Promoting Resilience in Wom ...

Enrolling

Breast Cancer

Metastatic Breast Cancer

Behavioral: Promoting Resilience in Women with Breast Cancer (PRISM)

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States and 1 other location

Olaparib in Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting

Somatic Mutation Breast Cancer (BRCA1)

Somatic Mutation Breast Cancer (BRCA2)

Drug: Olaparib

Phase 2

•

Beth Israel Lahey Health

Durham, North Carolina, United States and 19 other locations

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Enrolling

Hormone Receptor Positive (HR+), HER2-negative Breast Cancer

Triple Negative Breast Cancer

Drug: Paclitaxel

Drug: Carboplatin

Phase 2

•

Laura M. Spring, MD

Durham, North Carolina, United States and 9 other locations

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Enrolling

Breast Cancer

Hormone Receptor Positive Breast Cancer

Drug: ADJUVANT ENDOCRINE THERAPY

Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

•

Dana-Farber Cancer Institute

Chapel Hill, North Carolina, United States and 27 other locations

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting

Breast Cancer

Drug: Pertuzumab

Drug: Trastuzumab

Phase 2

•